Please login to the form below

Not currently logged in
Email:
Password:

Norton Healthcare

This page shows the latest Norton Healthcare news and features for those working in and with pharma, biotech and healthcare.

GSK accused of delaying generic Seroxat in UK

GSK accused of delaying generic Seroxat in UK

market. The OFT, which is the government department responsible for protecting consumers, said GSK infringed competition law by making “ substantial payments” to Alpharma, Generics (UK) and Norton Healthcare to delay plans ... These payments were

Latest news

  • NHS news in brief

    NHS news in brief. Our weekly round of NHS and healthcare stories. ... The companies have been named as: Kent Pharmaceuticals, Norton Healthcare, the Goldshield Group, Generics UK, Ranbaxy Laboratories UK Unit, and Regent-GM Laboratories.

  • Sandoz in fraud probe

    Six companies were named as part of the initial investigation: Generics UK, Kent Pharmaceuticals, Regent-GM Laboratories, Goldshield, Norton Healthcare and Ranbaxy (UK).

  • Nine drug executives to be charged in generics fraud probe

    At the time, other companies named by the SFO as being under investigation were Generics UK (a unit of Merck KGaA), Kent Pharmaceuticals, Regent-GM Laboratories, Norton Healthcare (a subsidiary of

  • AZ defiant after Symbicort patent revoked

    AZ defiant after Symbicort patent revoked. The European Patent Office has upheld an appeal by two generic drug manufactures, Norton Healthcare and Generics UK, and revoked a patent for Symbicort. ... The European Patent Office (EPO) has upheld an appeal

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics